Literature DB >> 22240445

Novel tyrosine kinase signaling pathways: implications in vascular remodeling.

Sri N Batchu1, Vyacheslav A Korshunov.   

Abstract

PURPOSE OF REVIEW: This review summarizes the recent advances in molecular mechanisms by which five classes of receptor tyrosine kinases (RTKs) contribute to vascular remodeling. RECENT
FINDINGS: Recent findings have expanded our knowledge regarding RTK regulation. In particular, G-protein-coupled receptors, mineralocorticoid receptors, mechanical and oxidative stresses transactivate RTKs. These receptors are highly interactive with many downstream targets (including tyrosine kinases and other RTKs) and function as key regulatory nodes in a dynamic signaling network. Interactions between vascular and nonvascular (immune and neuronal) cells are controlled by RTKs in vascular remodeling. Inhibition of RTKs could be an advantageous therapeutic strategy for vascular disorders.
SUMMARY: RTK-dependent signaling is important for regulation of key functions during vascular remodeling. However, current challenges are related to integration of the data on multiple RTKs in vascular pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240445      PMCID: PMC3609430          DOI: 10.1097/MNH.0b013e3283503ce9

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  46 in total

1.  Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt.

Authors:  Matthew G Melaragno; Megan E Cavet; Chen Yan; Lung-Kuo Tai; Zheng-Gen Jin; Judith Haendeler; Bradford C Berk
Journal:  J Mol Cell Cardiol       Date:  2004-10       Impact factor: 5.000

2.  Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases.

Authors:  K Nagata; K Ohashi; T Nakano; H Arita; C Zong; H Hanafusa; K Mizuno
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

3.  Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB.

Authors:  Yewei Ma; Liping Zhang; Tao Peng; Jizhong Cheng; Shilpa Taneja; Jiqiang Zhang; Patrice Delafontaine; Jie Du
Journal:  Endocrinology       Date:  2005-12-01       Impact factor: 4.736

Review 4.  G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation.

Authors:  Shai Gavi; Elena Shumay; Hsien-yu Wang; Craig C Malbon
Journal:  Trends Endocrinol Metab       Date:  2006-02-07       Impact factor: 12.015

5.  Emerging role of IGF-1R in stretch-induced neointimal hyperplasia in venous grafts.

Authors:  Hannah Song; Amy L Mowbray; Michelle C Sykes; Hanjoong Jo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08       Impact factor: 8.311

Review 6.  Molecular and cellular aspects of the insulin-like growth factor I receptor.

Authors:  D LeRoith; H Werner; D Beitner-Johnson; C T Roberts
Journal:  Endocr Rev       Date:  1995-04       Impact factor: 19.871

Review 7.  Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.

Authors:  Rhian M Touyz
Journal:  Exp Physiol       Date:  2005-05-12       Impact factor: 2.969

8.  Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells.

Authors:  Megan E Cavet; Elaine M Smolock; Oktay H Ozturk; Cameron World; Jinjiang Pang; Atsushi Konishi; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

9.  Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats.

Authors:  M G Melaragno; D A Wuthrich; V Poppa; D Gill; V Lindner; B C Berk; M A Corson
Journal:  Circ Res       Date:  1998-10-05       Impact factor: 17.367

Review 10.  Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.

Authors:  Sadaharu Higuchi; Haruhiko Ohtsu; Hiroyuki Suzuki; Heigoro Shirai; Gerald D Frank; Satoru Eguchi
Journal:  Clin Sci (Lond)       Date:  2007-04       Impact factor: 6.124

View more
  5 in total

1.  Axl modulates immune activation of smooth muscle cells in vein graft remodeling.

Authors:  Sri N Batchu; Jixiang Xia; Kyung Ae Ko; Marvin M Doyley; Jun-Ichi Abe; Craig N Morrell; Vyacheslav A Korshunov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-14       Impact factor: 4.733

2.  Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression.

Authors:  Jianjun Huang; Ying Shi; Hui Li; Dunyong Tan; Meisongzhu Yang; Xiang Wu
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

3.  ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling.

Authors:  Likun Yan; Qingguo Du; Jianfeng Yao; Ruiting Liu
Journal:  Exp Ther Med       Date:  2016-11-08       Impact factor: 2.447

Review 4.  Tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.

Authors:  Jose A Gomez-Puerta; Attila Mócsai
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

5.  Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation.

Authors:  Joanna Säleby; Habib Bouzina; Salaheldin Ahmed; Jakob Lundgren; Göran Rådegran
Journal:  ERJ Open Res       Date:  2019-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.